A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Project: Research project

Description

A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
StatusActive
Effective start/end date10/31/1810/31/23

Funding

  • UNIV. OF OKLAHOMA HEALTH SCIENCES CENTER

Fingerprint

Endometrium
Cervix Uteri
Carcinoma
rucaparib
Bevacizumab